Cancer has become a major global health threat due to its high incidence and mortality. However, the development of anti-cancer drugs is limited by high costs, long cycles, and low success rates, slowing the progress of new treatments. As a method that simulates human cognitive functions, artificial intelligence (AI) has greatly improved the efficiency of drug development. Machine learning is a core part of AI and supports applications such as natural language processing and computer vision. This paper reviews recent advances in AI for optimizing anti-cancer drug discovery, development, and medication therapy management. First, we highlight the applications of AI in target identification, druggability assessment, drug screening, and repurposing. Second, we detail how AI optimizes drug combination therapy and clinical trial design. Finally, we describe the role of AI in treatment management, including nanoparticle delivery systems, personalized dosing, and adaptive therapy. AI greatly streamlines anti-cancer drug development and provides new directions for precision cancer therapy.
Liu et al. (Tue,) studied this question.